Liens UNIL

FR EN

Unisciences

Vous êtes ici: UNIL > Unisciences

Recherche
- Recherche
- Afficher les données
  de à

Centre de neurosciences psychiatriques - CNP

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

1472 publications

... | 2008 | 2007 | 2006 | 2005 | ...

2008

ABCB1 and cytochromes P450 genotypes and phenotypes: influence on clozapine plasma concentrations

Jaquenoud Sirot Eveline, Knezevic B., Perla Morena Gina, Baumann Pierre, Eap Chin Bin, 2008. pp. e465 dans , Canadian Journal of Clinical Pharmacology = Journal canadien de pharmacologie clinique. Peer-reviewed.

[serval:BIB_8F425FA35787]

Advantages of digital holographic microscopy for real-time full field absolute phase imaging

Colomb Tristan, Charrière Florian, Kühn Jonas, Marquet Pierre, Depeursinge Christian, 2008. Progress in Biomedical Optics and Imaging, 6861 (686109). Peer-reviewed.

[DOI][WoS][serval:BIB_2A9DF7F00A89]

Alpha rhythm and hypofrontality in schizophrenia

Knyazeva M. G., Jalili M., Meuli R., Hasler M., De Feo O., Do K. Q., 2008. Acta Psychiatrica Scandinavica, 118 (3) pp. 188-199. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7071CB4D9B5E]

Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.

Bochud M., Eap C.B., Maillard M., Johnson T., Vollenweider P., Bovet P., Elston R.C., Bergmann S., Beckmann J.S., Waterworth D.M. et al., 2008. BMC Medical Genomics, 1 (21) pp. 1-11. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D784077998C6]

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.

Crettol S., Besson J., Croquette-Krokar M., Hämmig R., Gothuey I., Monnat M., Déglon J.J., Preisig M., Eap C.B., 2008. Progress in Neuro-psychopharmacology and Biological Psychiatry, 32 (7) pp. 1722-1727. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5E88F9AD4B4A]

Axial sub-nanometer accuracy in digital holographic microscopy

Kühn Jonas, Charrière Florian, Colomb Tristan, Cuche Etienne, Montfort Frédéric, Emery Yves, Marquet Pierre, Depeursinge Christian, 2008. Measurement Science and Technology, 19 (7) p. 074007. Peer-reviewed.

[DOI][WoS][serval:BIB_B7E84A2FF674]

Brain dopamine response in human opioid addiction

Daglish Mark R.C., Williams Tim M., Wilson Sue J., Taylor Lindsay G., Eap Chin, Augsburger Marc, Giroud Christian, Brooks David J., Myles Judy S., Grasby Paul et al., 2008. British Journal of Psychiatry, 193 (1) pp. 65-72. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_12635496DEAC]

Can glutathione deficit be a risk factor in the disconnectivity syndrome

Do Kim Quang, 2008. pp. 29-30 dans Schizophrenia Research, Schizophrenia Research. Peer-reviewed.

[DOI][serval:BIB_C988F5E91303]

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.

Nikisch G., Eap C.B., Baumann P., 2008. Pharmacological research, 58 (5-6) pp. 344-347. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9AD9C8C6AC8A]

CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.

Crettol S., Venetz J.P., Fontana M., Aubert J.D., Pascual M., Eap C.B., 2008. Therapeutic Drug Monitoring, 30 (6) pp. 689-699. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BC6922E390E7]

Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein

Leuba G., Savioz A., Vernay A., Carnal B., Kraftsik R., Tardif E., Riederer I., Riederer B. M., 2008. Journal of Alzheimer's Disease, 15 (1) pp. 139-151. Peer-reviewed.

[WoS][Pmid][serval:BIB_DACEB4A886F8]

Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: an immunohistochemical study

Chiry O., Fishbein W.N., Merezhinskaya N., Clarke S., Galuske R., Magistretti P.J., Pellerin L., 2008. Brain Research, 1226 pp. 61-69. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_25A201618DBD]

Dual-wavelength digital holographic microscopy with sub-nanometer axial accuracy

Kühn Jonas, Charrière Florian, Colomb Tristan, Montfort Frédéric, Emery Yves, Marquet Pierre, Depeursinge Christian, 2008. Progress in Biomedical Optics and Imaging, 6995 (699503). Peer-reviewed.

[DOI][WoS][serval:BIB_68CB6ACCD1B4]

Dysfonctions sexuelles induites par les antidépresseurs et les antipsychotiques et leurs traitements

Martin-Du Pan Rémy, Baumann Pierre, 2008. Revue médicale suisse, 4 (150) pp. 758-762. Peer-reviewed.

[serval:BIB_5C88F5FB7E84]

Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis.

Sellner J., Ringer R., Baumann P., Perey M.J., Schmitt B., Leib S.L., 2008. Current Drug metabolism, 9 (1) pp. 83-88. Peer-reviewed.

[WoS][Pmid][serval:BIB_39996DF3240B]

Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala.

Allaman I., Papp M., Kraftsik R., Fiumelli H., Magistretti P.J., Martin J.L., 2008. Pharmacological Reports, 60 (6) pp. 1001-1007. Peer-reviewed.

[WoS][Pmid][serval:BIB_E230041A9254]

Genotyping to optimize antipsychotic drug treatment

Eap Chin, 2008. p. 86 dans International Journal of Neuropsychopharmacology, International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_72414C8617CE]

Gestörte Chronobiologie begüngstigt Depressionen: Resynchronisierung als Wirkprinzip

Baumann Pierre, 2008. Leading Opinions. Neurologie und Psychiatrie, 8 (4) pp. 8-10.

[serval:BIB_B70967D5C6B2]

Gestörte Chronobiologie begünstigt Depressionen. Resynchronisierung als Wirkprinzip

Baumann Pierre, 2008. Leading Opinions Neurologie & Psychiatrie, 8 (4) pp. 8-10.

[serval:BIB_A17AA742F702]

Glutathione deficit in schizophrenia: strategies to increase glutathione levels in in vitro and in clinical studies

Lavoie S., Steullet P., Murray M., Conus P., Cuenod M., Do K. Q., 2008. pp. A63-A63 dans 6th International Conference on Early Psychosis, Early Intervention in Psychiatry. Peer-reviewed.

[WoS][serval:BIB_E770F8086FDC]

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.

Lavoie S., Murray M.M., Deppen P., Knyazeva M.G., Berk M., Boulat O., Bovet P., Bush A.I., Conus P., Copolov D. et al., 2008. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 33 (9) pp. 2187-99. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_57F07E73D442]

Impact of oral Cannabis on driving skills and genetic vulnerability to psychotic symptoms

Giroud C., Eap C.B., Favrat B., Sporkert F., Augsburger M., Rochat B., Montoya J.P., Castella V., Mangin P., 2008., Beiträge zum XV. Symposium der Gesellschaft für Toxigologische und Forensische Chemie. - Mosbach, 18-21. April 2007 pp. 193-203 dans Pragst F., Aderjan R. (eds.) Aktuelle Beiträge zur Forensischen und Klinischen Toxikologie. Fahreignung, K.O.-Mittel, Toxikokinetik, Analytische Methoden, Symposium der Gesellschaft für Toxicologische und Forensische Chemie : XV, Gesellschaft für Toxigologische und Forensische Chemie.

[serval:BIB_FE71E278D1D4]

Increased creatinine kinase and rhabdomyolysis in anorexia nervosa.

Walder A., Baumann P., 2008. International Journal of Eating Disorders, 41 (8) pp. 766-767. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_213E3145393B]

Induction of brain aquaporin 9 (AQP9) in catecholaminergic neurons in diabetic rats.

Badaut J., Brunet J.F., Petit J.M., Guérin C.F., Magistretti P.J., Regli L., 2008. Brain research, 1188 pp. 17-24. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C2306F9A4D33]

Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients

Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B47AB7C75055]

La génétique de l'hypertension: rôle des gènes CYP3A5 et ABCB1 dans le contrôle de la tension artérielle

Bochud Murielle, Eap Chin B., Bovet Pascal, Burnier Michel, 2008. Kardiovaskuläre Medizin, 11 (11) pp. 353-360.

[serval:BIB_178322875288]

Maladie d'Alzheimer et vieillissement cérébral

Leuba Geneviève, 2008. Actualités psychologiques 21 pp. 77-92.

[serval:BIB_8C4BDD1D3C3A]

Metabolic syndrome and atypical antipsychotics: Recommendations and clinical management,Syndrome métabolique et antipsychotiques atypiques: Recommandations et prise en charge clinique

Choong Eva, Conus Philippe, Eap Chin, 2008. revue médicale suisse, 4 (171) pp. 1994-6.

[DOI][serval:BIB_A537F0B03C03]

Metabolism of psychotropic drugs in the human brain: significance for therapeutic drug monitoring ?

Baumann Pierre, 2008. dans Pharmacopsychiatrie, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_BA3C221ED9A4]

Mico-cocktail validation for CYP3A and CYP2D6 assessment using a low dose of midazolam (0.075 mg) and dextromethorphan (2.5 mg)

Daali Y., Samer C., Eap C., Rebsamen M., Rossier M., Dayer P., Desmeules J., 2008. pp. 80S dans 76e Assemblée annuelle de la Société Suisse de Médecine Interne, Médecine et Société, Medizin und Gesellschaft, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.

[serval:BIB_BE34F6BB97FB]

Modulation of astrocytic metabolic phenotype by proinflammatory cytokines

Gavillet M., Allaman I., Magistretti P.J., 2008. Glia, 56 (9) pp. 975-989. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3D444977EB7C]

Monographs on drugs which are frequently analyzed in therapeutic drug monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden

Rentsch K., Eap C.B., Fathi M., Grignaschi N., Magnin J.L., Thormann W., Todesco L., Werner D., 2008. LaboratoriumsMedizin = Journal of Laboratory Medicine, 32 (5) pp. 372-381. Peer-reviewed.

[URN][DOI][WoS][serval:BIB_B183FFF0DEF4]

N-Acetyl Cysteine as a glutathione precursor for schizophrenia-A double-blind, randomized, placebo-controlled trial

Berk Michael, Copolov David, Dean Olivia, Lu Kristy, Jeavons Sue, Schapkaitz Ian, Anderson-Hunt Murray, Judd Fiona, Katz Fiona, Katz Paul et al., 2008. Biological Psychiatry, 64 (5) pp. 361-368. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0A3618F15C92]

Neuronal plasticity: a new paradigm for resilience

Magistretti P.J., Ansermet F., 2008. Schweizer Archiv für Neurologie und Psychiatrie = Archives suisses de neurologie et de psychiatrie, 159 (8) pp. 475-479.

[serval:BIB_2280E4687A8F]

No influence of ABCB1 haplotypes on methadone dosage requirement

Crettol Séverine, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Hämmig Robert, Gothuey Isabelle, Monnat Martine, Eap Chin-Bin, 2008. Clinical Pharmacology and Therapeutics, 83 (5) pp. 668-669. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5CEBA2B2D973]

Non-covalent and covalent protein labeling in two-dimensional gel electrophoresis.

Riederer B.M., 2008. Journal of Proteomics, 71 (2) pp. 231-244. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_19BF080E7635]

Nutzen und Aktualität der Fachinformationen für das therapeutische Drug-Monitoring von Psychopharmaka: ein Vergleich mit der Evidenz aus der Literatur

Ulrich Sven, Laux Gerd, Müller-Oerlinghausen Bruno, Havemann-Reinecke Ursula, Riederer Peter, Zernig Gerald, Baumann Pierre, Hiemke Christoph, 2008. Psychopharmakotherapie, 15 (2) pp. 67-74. Peer-reviewed.

[WoS][serval:BIB_58C2F2F468D1]

Off-label utilization of antidepressants.

Zullino D.F., Schwartz B., Bilancioni R., Baumann P., 2008. Acta Medica (hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové, 51 (1) pp. 19-24. Peer-reviewed.

[Pmid][serval:BIB_F69E77235432]

Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response.

Viviani Danièle, Stoop Ron, 2008. Progress in Brain Research, 170 pp. 207-218. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_29585962A32D]

Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit

Zullino Daniele Fabio, Krenz Sonia, Eap Chin-Bin, Benguettat Djamel, Khan R., 2008. European Journal of Medical Research, 13 (1) pp. 15-20. Peer-reviewed.

[WoS][Pmid][serval:BIB_A385C95B7296]

Pharmacogenetics of clozapine: in vivo role of cytochrome P450 isoforms and P-Glycoprotein

Jaquenoud Sirot Eveline, Knezevic B., Perla Morena Gina, Baumann Pierre, Eap Chin Bin, 2008. dans Pharmacopsychiatry, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_7BD695DD2CB3]

Pharmacovigilance in psychiatry: pharmacogenetic tests and therapeutic drug monitoring are promising tools

Baumann P., 2008. Expert Review of Clinical Pharmacology, 1 (2) pp. 183-185. Peer-reviewed.

[DOI][Pmid][serval:BIB_AF09DBAABDCE]

Pharmakokinetik, Pharmakogenetik und therapeutisches Drug Monitoring

Hiemke C., Baumann P., 2008. pp. 375-397 dans Holsboer Florian, Gründer Gerhard, Benkert Otto (eds.) Handbuch der Psychopharmakotherapie, Springer.

[serval:BIB_A4F7EC703FA2]

Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape.

Fiumelli H., Riederer I.M., Martin J.L., Riederer B.M., 2008. Cell Motility and the Cytoskeleton, 65 (6) pp. 495-504. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9E23336CEDA9]

Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction.

Leuba G., Walzer C., Vernay A., Carnal B., Kraftsik R., Piotton F., Marin P., Bouras C., Savioz A., 2008. Neurobiology of disease, 30 (3) pp. 408-19. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DABA620B8E5F]

Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone.

Wedekind D., Jacobs S., Karg I., Luedecke C., Schneider U., Cimander K., Baumann P., Ruether E., Poser W., Havemann-Reinecke U., 2008. World Journal of Biological Psychiatry, 9 pp. 1-10. Peer-reviewed.

[DOI][Pmid][serval:BIB_14D1FF1E78F1]

Purpura and ecchymosis under carbamazepine, chloral hydrate and melitracen-flupentixol.

Walder A., Greil W., Baumann P., 2008. European Journal of Dermatology, 18 (1) pp. 103-104. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0C99B0046EBA]

Quetiapine in adolescents with psychosis: a 12 weeks open label trial

Holzer Laurent, Preuss Ulrich, Clarke Stephanie, Halfon Olivier, Baumann Pierre, 2008. p. 162 dans Schizophrenia Research, Schizophrenia Research. Peer-reviewed.

[DOI][serval:BIB_08A52DBB190A]

Real-time dual-wavelength digital holographic microscopy for extended measurement range with enhanced axial resolution

Kühn Jonas, Colomb Tristan, Pache Christophe, Charrière Florian, Montfort Frédéric, Cuche Etienne, Emery Yves, Marquet Pierre, 2008. Progress in Biomedical Optics and Imaging, 6861 (68610J). Peer-reviewed.

[DOI][WoS][serval:BIB_2D7A5EB95714]

Redox dysregulation and oxidative stress in schizophrenia: genetic and functional anomalies of glutathione synthesis in patients and experimental models involving GABA interneurons and NMDA receptors

Cuenod M., Do K.Q., 2008. p. 38 dans 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), Munich, GERMANY, JUL 13-17, 2008, International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_50E30C871E1E]

Response to "methadone-induced QTc prolongation: is it due to stereoselective block of hERG or to inappropriate QT interval correction?"

Crettol Séverine, Schlaepfer Jürg, Abriel Hugues, Eap Chin-Bin, 2008. Clinical Pharmacology and Therapeutics, 83 (5) p. 672. Peer-reviewed.

[DOI][WoS][serval:BIB_318CB91606C3]

Spezielle Arzneimittelinteraktionen

Hiemke C., Baumann P., 2008. pp. 1127-1144 dans Holsboer Florian, Gründer Gerhard, Benkert Otto (eds.) Handbuch der Psychopharmakotherapie, Springer.

[serval:BIB_B5DBE509D612]

Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizer: evidence of a safer cardiac profile of (R)-methadone

Eap Chin Bin, Crettol Séverine, Rougier Jean-Sébastien, Schläpfer Jürg, Sintra Grilo Liliana, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Carrupt Pierre-Alain, Abriel Hugues, 2008. pp. A6 dans 5th Regensburg Symposium on Clinical Pharmacology, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_E1A09D2D578F]

Suivi thérapeutique des médicaments (I). Les principes [Principles of therapeutic drug monitoring]

Widmer N., Csajka C., Werner D., Grouzmann E., Decosterd L.A., Eap C.B., Biollaz J., Buclin T., 2008. Revue Médicale Suisse, 4 (165) pp. 1644-1668. Peer-reviewed.

[Pmid][serval:BIB_56FB6F49D00F]

Suivi thérapeutique des médicaments (II). La pratique clinique [Therapeutic drug monitoring: clinical practice].

Widmer N., Werner D., Grouzmann E., Eap C.B., Marchetti O., Fayet A., Csajka C., Decosterd L.A., Buclin T., 2008. Revue Médicale Suisse, 4 (165) pp. 1649-1660. Peer-reviewed.

[Pmid][serval:BIB_53F56A1C36B3]

TDMplus: the combination of TDM, check for drug interactions and genotyping

Jaquenoud Sirot Eveline, Baumann Pierre, 2008. pp. A19 dans 5th Regensburg Symposium on Clinical Pharmacology - of Therapeutical Drug Monitoring - 8th Workshop of the TDM Workgroup of AGNP, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_11176496D021]

Terapia antidepressantami i dugie metodi letchenja depressivnich rasstoist

Sartorius Norman, Baghai Thomas C., Baldwin David S., Barrett Barbara, Brand Ursula, Fleischhacker Wolfgang, Goodwin Guy, Grunze Heinz, Knapp Martin, Leonard Brian E. et al., 2008. 215, Rossiiskoje obchestvo pcichjatrov.

[serval:BIB_58BDAC325BF9]

Text analysis and drug analysis: therapeutic drug monitoring in the prescription information

Ulrich Sven, Hiemke Christoph, Conca Antoinette, Kuss Hans-Joachim, Tatusch V., Baumann Pierre, 2008. p. 216 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_3C5CD96E702B]

The AGNP-TDM expert consensus guidelines 2004: a promising start !

Baumann Pierre, 2008. dans Pharmacopsychiatrie, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_937AB4D49A96]

Therapeutic monitoring of psychotropic drugs to improve compliance

Baumann Pierre, 2008. p. 86 dans International Journal of Neuropsychopharmacology, International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_500857235122]

Traitement pharmacologique de la schizophrénie: évaluation comparative de la qualité des recommandations de pratique clinique [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia]

Delessert D., Pomini V., Grasset F., Baumann P., 2008. L'Encéphale, 34 (1) pp. 93-100. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0971D5E3C788]

Wie wirksam sind Antidepressiva ?: zur Bedeutung von Plasmakonzentrations-Wirksamkeits-Studien

Hiemke Christoph, Ulrich Sven, Baumann Pierre, Broich Karl, Conca Andreas, Havemann-Reinecke Ursula, Gerlach Manfred, Haen Ekkehard, Laux Gerd, Müller-Oerlinghausen Bruno et al., 2008. Psychopharmakotherapie, 15 (4) pp. 162-163. Peer-reviewed.

[WoS][serval:BIB_C188CF3EFA65]

2007

Dépression: le point sur les traitements psychopharma- cologiques [Pharmacotherapy of depression: recent developments]

Baumann P., 2007/09/19. Revue medicale suisse, 3 (125) pp. 2079-2080,2083-2084. Peer-reviewed.

[Pmid][serval:BIB_2EEBAF4C185A]

Gluthatione percursor, N-acetyl-cysteine, modulates mimatch negativity generation in schizophrenia patients

Lavoie S., Murray M., Knyazeva M., Bovet P., Buclin T., Conus P., Deppen P., Meuli R., Solida A., Cuenod M. et al., 2007/03. pp. N/A dans 2007.03.9-10, SSN - NCCR Neuro - SSMS joint meeting, Von Roll Areal, University of Bern, Switzerland. Book of abstract P. 96. Poster I19..

[serval:BIB_92F7B7146593]

The hole-head EEG synchronization landscape in schizophrenia with a new method of S-estimator

Knyazeva M., Jalili M., Do Cuenod K., Bovet P., Cuenod M., Deppen P., Meuli R., Maeder P., Lavoie S., Hasler M. et al., 2007/03. pp. N/A dans SSN - NCCR Neuro - SSMS joint meeting, Von Roll Areal, University of Bern, Switzerland. Book of abstract P.138. PosterJ66.

[serval:BIB_12CFEEEEFF98]

A critical role for system A amino acid transport in the regulation of dendritic development by brain-derived neurotrophic factor (BDNF).

Burkhalter J., Fiumelli H., Erickson J.D., Martin J.L., 2007/02. Journal of Biological Chemistry, 282 (8) pp. 5152-5159. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_630BD891ADA7]

A coherent neurobiological framework for functional neuroimaging provided by a model integrating compartmentalized energy metabolism.

Aubert A., Pellerin L., Magistretti P.J., Costalat R., 2007. Proceedings of the National Academy of Sciences of the United States of America, 104 (10) pp. 4188-93. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_96CBD96079D8]

A glutathione precursor, N-acetyl-cysteine, modulates mismatch negativity generation in schizophrenia patients

Lavoie Suzie, Murray Micah M., Knyazeva Maria, Bovet Pierre, Buclin Thierry, Conus Philippe, Deppen Patricia, Meuli Reto, Solida Alessandra, Cuénod Michel et al., 2007. p. 440 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][WoS][serval:BIB_BF6D5D38D045]

Activity-dependent regulation of energy metabolism by astrocytes: an update.

Pellerin L., Bouzier-Sore A.K., Aubert A., Serres S., Merle M., Costalat R., Magistretti P.J., 2007. Glia, 55 (12) pp. 1251-62. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_507BA446FCDD]

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

Sartorius N., Baghai T.C., Baldwin D.S., Barrett B., Brand U., Fleischhacker W., Goodwin G., Grunze H., Knapp M., Leonard B.E. et al., 2007. International Journal of Neuropsychopharmacology, 10 (Suppl. 1) pp. S1-S207. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_157523158DCC]

Begünstigen Antidepressiva die Suizidalität und die Suizidrate von Depressiven?

Hättenschwiler Josef, Baumann Pierre, Hatzinger Martin, Höck Paul, Holsboer-Trachsler Edith, Jost Martin, Nil Rico, Ramseier Fritz, Seifritz Erich, Zullino Daniele et al., 2007. Schweiz Med Forum, 7 pp. 757-764.

[serval:BIB_CB46E41BD043]

Biology of freedom : neural plasticity, experience, and the unconscious

Ansermet François, Magistretti Pierre, 2007. 254, Other Press.

[serval:BIB_66748F69EA1C]

CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription.

Ceseña T.I., Cardinaux J.R., Kwok R., Schwartz J., 2007/01. Journal of Biological Chemistry, 282 (2) pp. 956-967. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_86E9A62178C5]

Clinical consequences of imatinib plasma concentrations variability in hemato-oncologic patients

Widmer N., Leyvraz S., Duchosal M.A., Rosselet A., Csajka C., Henry H., Debiec-Rychter M., Eap C.B., Biollaz J., Buclin T. et al., 2007. p. 481 dans 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Therapeutic Drug Monitoring. Peer-reviewed.

[WoS][serval:BIB_6B840EC11A9C]

Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?

Crettol S., Monnat M., Eap C.B., 2007. Critical Care, 11 (1) p. 119. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_4436790B32FC]

CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.

Eap C.B., Bochud M., Elston R.C., Bovet P., Maillard M.P., Nussberger J., Schild L., Shamlaye C., Burnier M., 2007. Hypertension, 49 (5) pp. 1007-14. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_271777C1AEDD]

Determination and distribution of clotiapine (Entumine) in human plasma, post-mortem blood and tissue samples from clotiapine-treated patients and from autopsy cases

Sporkert Frank, Augsburger Marc, Giroud Christian, Brossard Clarisse, Eap Chin-Bin, Mangin Patrice, 2007. Forensic Science International, 170 (2/3) pp. 193-199. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_349D98D54E8D]

Dysconnection topography in schizophrenia revealed with state-space analysis of EEG.

Jalili M., Lavoie S., Deppen P., Meuli R., Do K.Q., Cuénod M., Hasler M., De Feo O., Knyazeva M.G., 2007. PLoS ONE, 2 (10) pp. e1059. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_97331B9E07D6]

Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study

Le Bloc'h Yves, Baumann Pierre, Stigler Michael, Eap Chin-Bin, Zullino Daniele Fabio, 2007. International Journal of Psychiatry in Clinical Practice, 11 (2) pp. 123-128. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F36241EE32C5]

Glutathione deficit alters dopamine modulation of NMDA-mediated calcium responses via D2 receptormediated signalling pathway: implication of ryanodine receptors and L-type calcium channels

Steullet Pascal, Lavoie Suzie, Guidi Raffaella, Kraftzig R., Cuénod Michel, Do Kim Quang, 2007. p. 316 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_2D9FC5868635]

Imaging EEG synchronization in schizophrenia patients with S-estimator

Knyazeva Maria G., Jalili M., Do Kim Quang, Bovet Pierre, Cuénod Michel, Deppen Patricia, Meuli Reto, Maeder Philippe, Lavoie Suzie, Vianin Pascal et al., 2007. p. 374 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_22EB7F665FDC]

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence

Gysin R., Kraftsik R., Sandell J., Bovet P., Chappuis C., Conus P., Deppen P., Preisig M., Ruiz V., Steullet P. et al., 2007. Proceedings of the National Academy of Sciences of the United States of America, 104 (42) pp. 16621-16626. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_701A10B9CD06]

In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites

Crettol Séverine, Digon Patricia, Powell Golay Kerry, Brawand Marlyse, Eap Chin-Bin, 2007. Pharmacology, 80 (4) pp. 304-311. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7DD3F39D7F18]

Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients

Uehlinger Claude, Crettol Séverine, Chassot Philippe, Brocard Murielle, Koeb Liliane, Brawand-Amey Marlyse, Eap Chin-Bin, 2007. Journal of Clinical Psychopharmacology, 27 (3) pp. 273-278. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_14C9CA4BBD65]

Les antidépresseurs favorisent-ils la suicidalité et le suicide chez les individus dépressifs?

Hättenschwiller Joseph, Baumann Pierre, Hatzinger Martin, Höck Paul, Holsboer-Trachsler Edith, Jost Martin, Nil Rico, Ramseier Fritz, Seifritz Erich, Zullino Daniele et al., 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (37) pp. 757-764. Peer-reviewed.

[serval:BIB_0D50C724AE70]

Metabolic compartmentalization in the human cortex and hippocampus: evidence for a cell- and region-specific localization of lactate dehydrogenase 5 and pyruvate dehydrogenase.

Laughton J.D., Bittar P., Charnay Y., Pellerin L., Kovari E., Magistretti P.J., Bouras C., 2007. BMC neuroscience, 8 p. 35. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6CEBA0038483]

Micro-cocktail validation for CYP3A and CYP2D6 assessment using a low dose of midazolam (0.075 mg) and dextromethorphan (2.5 mg)

Daali Youssef, Samer C., Eap Chin-Bin, Rebsamen Michaëla, Rossier Michel, Dayer Pierre, Desmeules Jules, 2007. pp. S77-S77 dans , Clinical Pharmacology and Therapeutics. Peer-reviewed.

[DOI][serval:BIB_B5827BA589B8]

Médicaments et autres traitements des troubles dépressifs : revue technique des preuves scientifiques réalisée par un groupe de travail du CINP [Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence].

Baghai Thomas C., Baldwin David S., Barret Barbara, Bauman Pierre, Ghalib Kareem, Goodwin Guy, Grunze Heinz, Knapp Martin, Leonard Brian E., Markowitz John C. et al., 2007/01/01. 526, CINP Task Force.

[serval:BIB_12D1B854605E]

Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements

Saraeva R. B., Paskaleva I. D., Doncheva E., Eap Chin-Bin, Ganev V. S., 2007. Journal of Clinical Pharmacy and Therapeutics, 32 (6) pp. 641-649. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6255C84E88F0]

Pharmacokinetic and pharmacogenetic factors influencing methadone plasma levels

Crettol Séverine, Eap Chin-Bin, 2007. Heroin Addiction and Related Clinical Problems, 9 (2) pp. 39-46. Peer-reviewed.

[serval:BIB_E8D5A9077B7E]

Pharmacokinetic influences on treatment of the elderly

Baumann Pierre, 2007. pp. 296-340 dans , International Journal of Psychiatry in Clinical Practice. Peer-reviewed.

[DOI][serval:BIB_D8C69186098D]

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

Baumann Pierre, Jaquenoud Sirot Eveline, Hiemke Christoph, Bengtsson Finn, 2007. p. 96 dans , European Psychiatry. Peer-reviewed.

[DOI][WoS][serval:BIB_3AA3CB95322A]

Recommandations de pratique clinique dans la schizophrénie: de la théorie à la mise en application = Clinical practice guidelines for the treatment of schizophrenia: from theory to practice

Delessert D., Pomini V., Grasset F., Baumann P., 2007. Encéphale, 33 (6) pp. 902-910. Peer-reviewed.

[DOI][WoS][serval:BIB_20A3F982AC9A]

Redox dysregulation and oxidative stress in schizophrenia: genetic and fuctional anomalies in glutathione synthesis

Do Kim Quang, Cabungcal Jan Harry, Gysin René, Lavoie Suzie, Steullet Pascal, Tosic Mirjana, Cuénod Michel, 2007. p. 278 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_9CAF5C1ED9B6]

Replenishment of glutathione levels in neurons and astrocytes with compromised GCL activity: relevance to schizophrenia

Lavoie Suzie, Steullet Pascal, Gysin René, Cuénod Michel, Chen Y., Dalton T.P., Do Kim Quang, 2007. p. 318 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_F557C764F44A]

Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?

Mathé A.A., Husum H., El Khoury A., Jiménez-Vasquez P., Gruber S.H., Wörtwein G., Nikisch G., Baumann P., Agren H., Andersson W. et al., 2007. Physiology and Behavior, 92 (1-2) pp. 226-231. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9A0AE7AC878C]

Selective serotonin reuptake inhibitors in adolescent depression still controversial

Holzer L., Baumann P., 2007. Journal of clinical psychopharmacology, 27 (3) pp. 325-6; author reply 326. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AD4724F82DF1]

Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.

Eap C.B., Crettol S., Rougier J.S., Schläpfer J., Sintra Grilo L., Déglon J.J., Besson J., Croquette-Krokar M., Carrupt P.A., Abriel H., 2007. Clinical Pharmacology and Therapeutics, 81 (5) pp. 719-728. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DBDA92B48C27]

The ABCB1 2677 G>T and 3435 C>T variants are associated with glomerular filtration rate in African families [Abstract]

Bochud Murielle, Eap Chin-Bin, Maillard Marc P., Elston Robert C., Bovet Pascal, Shamlaye Conrad, Burnier Michel, 2007. dans Biomedical imaging, CHUV Research Day, February 1, 2007. - Lausanne : CHUV, 2007. - MCV-32, p. 112, CHUV Research Day.

[serval:BIB_1793FC312CF6]

Therapeutic drug monitoring of antidepressants--clinical aspects

Laux G., Baumann Pierre, Hiemke C., T. D. M. group of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie, 2007. J Neural Transm Suppl 72 pp. 261-7.

[Pmid][serval:BIB_78F2D0F61EA7]

Thrombin-induced ischemic tolerance is prevented by inhibiting c-jun N-terminal kinase.

Granziera C., Thevenet J., Price M., Wiegler K., Magistretti P.J., Badaut J., Hirt L., 2007. Brain research, 1148 pp. 217-25. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_BB52355D3C0B]

Time course of response to paroxetine: influence of plasma level

Gex-Fabry Marianne, Gervasoni Nicola, Eap Chin-Bin, Aubry Jean-Michel, Bondolfi Guido, Bertschy Gilles, 2007. Progress in Neuro-psychopharmacology & Biological Psychiatry, 31 (4) pp. 892-900. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_881B6AF3377A]

TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity.

Kovács K.A., Steullet P., Steinmann M., Do K.Q., Magistretti P.J., Halfon O., Cardinaux J.R., 2007. Proceedings of the National Academy of Sciences of the United States of America, 104 (11) pp. 4700-5. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B1CFB71D5F21]

Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: relevance to schizophrenia.

Cabungcal J.H., Preissmann D., Delseth C., Cuénod M., Do K.Q., Schenk F., 2007. Neurobiology of disease, 26 (3) pp. 634-45. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7F3A71AB485F]

Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence

Ulrich Sven, Hiemke Christoph, Laux Gerd, Müller-Oerlinghausen Bruno, Havemann-Reinecke U., Riederer Peter, Zernig Gerald, Baumann Pierre, 2007. Pharmacopsychiatry, 40 (3) pp. 121-127. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8413DCBFD575]

2006

Neuron-glia metabolic coupling and plasticity.

Magistretti P.J., 2006/06. The Journal of experimental biology, 209 (Pt 12) pp. 2304-2311. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D3007D74BB3E]

Psychotropic drug prescriptions in hospitalized elderly psychiatric patients: comparison with adult psychiatric patients

ZULLINO Daniele F., REYNAUD Gilbert, DE MENDONCA LIMA Carlos Augusto, BAUMANN Pierre, 2006/06. Psychogeriatrics, 6 (2) pp. 68-73. Peer-reviewed.

[DOI][serval:BIB_E666B3DB4A61]

A key role for hypocretin in regulating brain reward function and reinstatement for drug seeking behaviour in rats

Boutrel Benjamin, Kenny Paul J., Specio Sheila E., Halfon Olivier, Magistretti Pierre J., Markou Athina, Koob George F., Lecea L. de , 2006. p. 16 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_B0436DAF0FFD]

A prefrontal cortex defect of glutamate release capacity in the phencyclidine (PCP) model of schizophrenia

Baccaglioni Emanuela, Brambilla L., Magara Fluvio, Magistretti Pierre J., Volterra A., 2006. p. 5 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_7461FB51A992]

ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.

Crettol S., Déglon J.J., Besson J., Croquette-Krokar M., Hämmig R., Gothuey I., Monnat M., Eap C.B., 2006. Clinical pharmacology and therapeutics, 80 (6) pp. 668-81. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D9E02532BEA1]

Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity

Stephan P.L., Jaquenoud Sirot E., Mueller B., Eap C.B., Baumann P., 2006. Pharmacopsychiatry, 39 (4) pp. 150-2. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FD70580355FC]

Allostatic working memory processing in schizophrenia: Human and animal model coherence

Cocchi Laurent, Preissmann Delphine, Do Kim Quang, Vianin Pascal, Schenk Françoise, 2006. pp. 14-15 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_6607000CE16C]

Apport de la pharmacogénétique dans le traitement médicamenteux des addictions : l'exemple de la méthadone

Eap C.B., Baumann P., 2006. pp. 65-70 dans Suchtforschung des BAG. Recherches de l'OFSP en matière de dépendances 2002-03, Bundesamt für Gesundheit.

[URN][serval:BIB_0953690D575B]

Aripiprazole and suicidality.

Holzer L., Eap C.B., 2006. International clinical psychopharmacology, 21 (2) pp. 125-6. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2FD9DEC2C785]

Assessment of stress and behavioural effects induced by 'CaResS' a new device designed for sleep restriction/deprivation studies in mice

Petit J., Haeberli C., Singy A., Laughton J.D., Steimer T., Magistretti Pierre J., 2006. pp. 170-171 dans , Journal of Sleep Research. Peer-reviewed.

[serval:BIB_BE26D15F343D]

Association of CYP3A5 genotypes with blood pressure and renal function in African families.

Bochud M., Eap C.B., Elston R.C., Bovet P., Maillard M., Schild L., Shamlaye C., Burnier M., 2006. Journal of hypertension, 24 (5) pp. 923-9. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2174105C05DE]

C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones.

Kovács K.A., Steinmann M., Magistretti P.J., Halfon O., Cardinaux J.R., 2006. Journal of neurochemistry, 98 (5) pp. 1390-9. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8A3BC09D7768]

Clinical relevance of TDM of SSRIs

Schwarz Markus J., Hiemke Christoph, Baumann Pierre, 2006. Therapeutic Drug Monitoring, 28 (5) pp. 716-717. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_993ADB1C0E9A]

Dose-dependent venlafaxine-induced hair loss

Jaquenoud Sirot Eveline, Etzensberger M., Eap Chin-Bin, Baumann Pierre, 2006. p. 939 dans , Drug Safety. Peer-reviewed.

[serval:BIB_1AEB8C64710D]

Drug monographs on drugs which are frequently analysed in the context of Therapeutic Drug Monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden

Rentsch Katharina, Baumann Pierre, Fathi Marc, Grignaschi Nathalie, Magnin Jean-Luc, Thormann Wolfgang, Todesco Liliane, Wenk Markus, Werner Dominique, 2006. LaboratoriumsMedizin = Journal of Laboratory Medicine, 30 (6) pp. 443-452. Peer-reviewed.

[URN][DOI][serval:BIB_2534A7E3A40F]

Dysregulation of Glutathione Metabolism: A Risk Factor for Schizophrenia

Gysin René, Tosic Curnier Mirjana, Chappuis Céline, Deppen Patricia, Ruiz Viviane, Cuénod Michel, Do Kim Quang, 2006. p. 6 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_AA401DC6AE7A]

Dépendances [Addictions]

Besson J., Eap C., Rougemont-Buecking A., Simon O., Nikolov C., Bonsack C., Gothuey I., 2006. Revue médicale suisse, 2 (47) pp. 9-13. Peer-reviewed.

[Pmid][serval:BIB_86AEDBE730C0]

Epidemiology of major depression: how is the view changing ?

Schlaepfer T.E., Baumann Pierre, 2006. pp. 13-14 dans , Parkinsonism and Related Disorders. Peer-reviewed.

[serval:BIB_BE1AEA2F628C]

Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.

Baumann P., Barbe R., Vabre-Bogdalova A., Garran E., Crettol S., Eap C.B., 2006. Journal of clinical psychopharmacology, 26 (6) pp. 679-81. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C2275B85B7A2]

Epileptiform seizure following sertraline treatment in an adolescent suffering from obsessive compulsive disorder and presenting a rare pharmacogenetic status

Baumann Pierre, Barbe R., Vabre-Bogdalova A., Garran E., Crettol Séverine, Eap Chin B., 2006. Journal of Clinical Psychopharmacology, 26 (6) pp. 679-681.

[serval:BIB_904321AD6133]

Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex.

Chiry O., Pellerin L., Monnet-Tschudi F., Fishbein W.N., Merezhinskaya N., Magistretti P.J., Clarke S., 2006. Brain Research, 1070 (1) pp. 65-70. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F17C9ACD8257]

Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies

van Leeuwen F.W., van Tijn P., Sonnemans M.A.F., Hobo B., Mann D.M.A., Van Broeckhoven C., Kumar-Singh S., Cras P., Leuba Geneviève, Savioz Armand et al., 2006. Neurology, 66 (Suppl. 1) pp. 86-92. Peer-reviewed.

[DOI][WoS][serval:BIB_DBF662BD22F1]

Genetic polymorphisms of CYP3A genes affect cyclosporine a blood concentration and dose requirement in transplant recipients

Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.

[serval:BIB_1DF48FD34AEB]

Genetic vulnerability factor for schizophrenia: association with glutamate cysteine ligase modifier gene and abnormal enzyme activity

Tosic Curnier Mirjana, Ott Jurg, Barral Sandra, Bovet Pierre, Deppen Patricia, Gheorghita F., Matthey Marie-Louise, Parnas Josef, Preisig Martin, Saraga Michael et al., 2006. p. 5 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_6DFCFB855244]

Glucose and lactate are equally effective in energizing activity-dependent synaptic vesicle turnover in purified cortical neurons.

Morgenthaler F.D., Kraftsik R., Catsicas S., Magistretti P.J., Chatton J.Y., 2006. Neuroscience, 141 (1) pp. 157-65. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_52D625761B9E]

Glutathione (GSH) Deficit in Schizophrenia: dysfunction of NMDA Receptors and Alteration of Dopamine Modulation of NMDA Responses

Steullet Pascal, Lavoie Suzie, Guidi Raffaella, Do Kim Quang, Cuénod Michel, 2006. p. 3 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_1D61D7EF49F3]

Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia

Cabungcal Jan Harry, Nicolas D., Kraftsik Rudolf, Cuénod Michel, Do Kim Quang, Hornung J.P., 2006. p. 6 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_C85B77CA4903]

Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia.

Cabungcal J.H., Nicolas D., Kraftsik R., Cuénod M., Do K.Q., Hornung J.P., 2006. Neurobiology of disease, 22 (3) pp. 624-37. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_012EAAA6447D]

Glutathione Deficit in Schizophrenia: Replenishment of Glutathione Levels in Neurons and Astrocytes Models

Lavoie Suzie, Steullet Pascal, Cuénod Michel, Do Kim Quang, 2006. p. 6 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_5E0D22C44FE8]

Influence of MDR1 genetic polymorphisms on intralymphocyte concentrations of cyclosporine A in transplant recipients

Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Ansermot Nicolas, Fathi Marc, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.

[serval:BIB_2593E2C77971]

Le dosage plasmatique des médicaments psychotropes à des fins thérapeutiques: recommandations du groupe d'experts AGNP-TDM

Baumann Pierre, Hiemke Christoph, Ulrich Sven, Eckermann Gabriel, Kuss H.L., Laux Gerd, Muller-Oerlingenhausen B., Rao Marie Luise, Riederer Peter, Zernig Gerald, 2006. Revue médicale suisse, 2 (67) pp. 1413-1418. Peer-reviewed.

[Pmid][serval:BIB_2D16AD94CF56]

Le lactate est-il un substrat énergétique majeur pour les neurones [Is lactate a major energy substrate for neurons?]

Costalat R., Aubert A., Magistretti P.J., Pellerin L., 2006. Médecine sciences : M/S, 22 (4) pp. 356-7. Peer-reviewed.

[WoS][Pmid][serval:BIB_E2CA119FBBA3]

L’Information psychiatrique

Choong Eva, eap chin, 2006/01/01. Syndrome métabolique et antipsychotiques atypiques: recommandations et prise en charge clinique..

[serval:BIB_3DD17661DFF9]

Metabolic activation pattern of distinct hippocampal subregions during spatial learning and memory retrieval.

Ros J., Pellerin L., Magara F., Dauguet J., Schenk F., Magistretti P.J., 2006. Journal of Cerebral Blood Flow and Metabolism, 26 (4) pp. 468-477. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_EE95170D1BB4]

Mirtazapine enantiomers in blood and cerebrospinal fluid

Baumann Pierre, Jonzier Perey Michèle, Paus Erik, Nikisch Georg, 2006. Neuropsychobiology, 54 (3) pp. 179-181. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_30C59CF45DF9]

Neuron-glia metabolic coupling and plasticity

Magistretti Pierre J., 2006. pp. 296-296 dans , International Journal of Psychophysiology. Peer-reviewed.

[DOI][serval:BIB_0AF6913B12C4]

Neuropeptide Y (NPY) and corticotropinreleasing hormone (CRH) in human CSF and in brain of animal models of depression

Mathé Aleksander A., Agren Hans, Andersson Weronica, Baumann Pierre, El Khoury Aram, Gruber Susanne H.M., Jiménez-Vasquez Patricia, Nikisch Georg, Wörtwein Gitta, 2006. p. 74 dans , International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_034843468787]

Neuropeptidergic modulation of brain stem projections from the central amygdala: an in vitro and in vivo study

Viviani Danièle, Poisbeau P., Stoop Ronaldus, 2006. p. 19 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_D40A117BF2DB]

Neuropeptides in human cerebrospinal fluid and in brains of animal models of depression - effects of treatment

Mathé Aleksander A., Nikisch Georg, Agren Hans, Baumann Pierre, El Khoury Aram, Gruber Susanne H.M., Husum Henriette, Jiménez-Vasquez Patricia, Wörtwein Gitta, Andersson Weronica et al., 2006. pp. 308-309 dans , European Neuropsychopharmacology. Peer-reviewed.

[serval:BIB_3700339B02D1]

Off-label utilization of antipsychotics

Zullino Daniele Fabio, Bilancioni Romain, Conus Philippe, Schwartz B., Khazaal Yasser, Baumann Pierre, 2006. South African Psychiatry Review, 9 (1) pp. 38-43. Peer-reviewed.

[serval:BIB_A3676EFD6441]

Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.

Colombo S., Buclin T., Décosterd L.A., Telenti A., Furrer H., Lee B.L., Biollaz J., Eap C.B. and , 2006. Clinical pharmacology and therapeutics, 80 (4) pp. 307-18. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_859F62D8CAD6]

Pharmacogenomics of opioids

Crettol Séverine, Eap Chin-Bin, 2006. dans Pharmacogenomics and proteomics : enabling the practice of personalized medicine / ed. by Steven H.Y. Wong, Mark W. Linder, Roland Valdes. - Washington, DC : AAC Press, 2006. - P. 187-198. - ISBN 1594250464, NA.

[serval:BIB_2779A49BFF28]

Pharmacokinetics and interaction in old age

Baumann Pierre, 2006. p. 319 dans , International Journal of Psychiatry in Clinical Practice. Peer-reviewed.

[DOI][serval:BIB_5BD8AA024F40]

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

Widmer N., Decosterd L.A., Csajka C., Leyvraz S., Duchosal M.A., Rosselet A., Rochat B., Eap C.B., Henry H., Biollaz J. et al., 2006. British journal of clinical pharmacology, 62 (1) pp. 97-112. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6058765DDE09]

Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening.

Bonsack C., Camus D., Kaufmann N., Aubert A.C., Besson J., Baumann P., Borgeat F., Gillet M., Eap C.B., 2006. Addictive behaviors, 31 (7) pp. 1252-8. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FD2258F80A77]

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

Baumann Pierre, 2006. p. 64 dans , European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_C0085B5111A4]

Recommandations du groupe d'experts AGNP-TDM: le monitoring à but thérapeutique des médicaments psychotropes

Baumann Pierre, 2006. pp. 26-27 dans , European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_C2BF59C278B6]

Replenishment of glutathione levels in neurons and astrocytes with compromised GCL activity: relevance to schizophrenia

Lavoie Suzie, Steullet Pascal, Gysin René, Cuénod Michel, Chen Y., Dalton T.P., Do Kim Quang, 2006. dans , Abstracts - Society for Neuroscience. Peer-reviewed.

[serval:BIB_A156ADD620EE]

Risperidone-induced symptomatic hyperprolactinaemia in adolescents.

Holzer L., Eap C.B., 2006. Journal of clinical psychopharmacology, 26 (2) pp. 167-171. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2BC65C3A1135]

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.

Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., Matthey M.L., Parnas J., Preisig M., Saraga M. et al., 2006. American journal of human genetics, 79 (3) pp. 586-92. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FC5ABE3EB470]

Schizophrenia connectivity: correlation between cognitive deficits and reduced thalamo-cortical fibers

Deppen Patricia, Cammoun L., Chappuis Céline, Bovet Pierre, Cuénod Michel, Thiran J.P., Meuli Reto, Do Kim Quang, 2006. p. 11 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_8920C1D9E1C4]

Synaptic changes in the lateral amygdala as an underlying factor for the high concordance rate of anxiety disorders and temporal lobe epilepsy

Pickenhagen A., Magistretti Pierre J., Stoop Ronaldus, 2006. p. 19 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_CE9BF85F1D1F]

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia

Steullet Pascal, Neijt H.C., Cuénod Michel, Do Kim Quang, 2006. Neuroscience, 137 (3) pp. 807-819. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2A84208B5C49]

The frontal cortex may be the site of synaptic and cytoskeleton reorganization in Alzheimer's disease

Leuba Geneviève, Carnal B., Vernay André, Kraftsik Rudolf, Riederer Beat Michel, 2006. p. 4 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_F24B14804D3C]

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Jaquenoud Sirot E., van der Velden J.W., Rentsch K., Eap C.B., Baumann P., 2006. Drug safety, 29 (9) pp. 735-768. Peer-reviewed.

[WoS][Pmid][serval:BIB_D30C2EFDB3C6]

Working memory in schizophrenia: dynamic visuo-spatial information processing

Deppen Patricia, Cuénod Michel, Do Kim Quang, Bovet Pierre, Vianin Pascal, 2006. p. 14 dans , Neuropsychobiology. Peer-reviewed.

[DOI][serval:BIB_DF9B8F0B4CC0]

2005

A key role for hypocretin in regulating brain reward function and reinstatement for drug-seeking behavior in rats

Boutrel Benjamin, Kenny Paul J., Specio Sheila E., Winsky-Sommerer Raphaëlle, Halfon Olivier, Magistretti Pierre J., Markou Athina, Koob George F., Lecea Luis de, 2005. p. 60 dans , Behavioural Pharmacology. Peer-reviewed.

[serval:BIB_BEEA00E38C4F]

Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators.

Pellerin L., Magistretti P.J., 2005. Journal of neurochemistry, 92 (3) pp. 668-77. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2C2508B274B3]

Antidepressiva : Pharmakologie, therapeutischer Einsatz und Klinik der Depressionen

Breyer-Pfaff Ursula, Gaertner Hans Jörg, Baumann Pierre, 2005., 2., völlig neu bearb. Aufl. 159, WVG.

[serval:BIB_717CB47E4B31]

Association between plasma and cerebrospinal fluid (CSF) concentrations of SSRI's and newer antidepressants and their metabolites with 5-hydroxyindoleacetic (5-HIAA) and clinical outcom in depressed patients

Nikisch Georg, Mathé Aleksander A., Baumann Pierre, 2005. p. 95 dans , World Journal of Biological Psychiatry. Peer-reviewed.

[serval:BIB_69C45C5E441A]

Association between the CYP3A5 A698G polymorphism and blood pressure in individuals of east African descent

Eap Chin-Bin, Bochud Murielle, Elston Robert C., Bovet Pascal, Maillard Marc P., Burnier Michel, 2005. pp. MCV-042, p. 145 dans , CHUV Research Day.

[serval:BIB_846A5683065D]

Association of glutathione related genes with the risk of schizophrenia

Tosic Mirjana, Ott Jurg, Barral Sandra, Bovet Pierre, Deppen Patricia, Gheorghita F., Matthey Marie-Louise, Preisig Martin, Saraga Michael, Solida Alessandra et al., 2005. dans , Abstracts - Society for Neuroscience. Peer-reviewed.

[serval:BIB_A47F02B6E06B]

Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation.

Aubert A., Costalat R., Magistretti P.J., Pellerin L., 2005. Proceedings of the National Academy of Sciences of the United States of America, 102 (45) pp. 16448-53. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C04195B31BC9]

Citalopram - Plasma- und Liquor- konzentrationen: Zusammenhand mit neurobiologischen und klinischen Verlaufsparametern

Nikisch Georg, Mathé Aleksander A., Baumann Pierre, 2005. Psychopharmakotherapie, 12 (4) pp. 130-134. Peer-reviewed.

[WoS][serval:BIB_FF142CFD048B]

Citalopram - Plasma- und Liquorkonzentrationen - Zusammenhang mit neurobiologischen und klinischen Verlaufsparametern

Nikisch Georg, Mathé Alexander A., Baumann Pierre, 2005. Psychopharmakotherapie, 12 (4) pp. 130-134.

[serval:BIB_7F51292FB850]

Clinical relevance of citalopram (CIT) plasma and cerebrospinal fluid (CSF) concentrations: impact with CSF monoamine metabolites

Nikisch C., Mathé Aleksander A., Baumann Pierre, 2005. p. 59 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_95E410AA9416]

CYP2D6 genotype in relation to steady state concentrations of mirtazapine, N-desmethylmirtazapine and their enantiomers

Lind A.B., Reis M., Bengtsson Finn, Ahlner Johan, Eap Chin-Bin, Baumann Pierre, Dahl M.L., 2005. p. 124 dans , Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.

[serval:BIB_EB257DCCC0D0]

Die Individualität des Gehirns : Neurobiologie und Psychoanalyse

Ansermet François, Magistretti Pierre, 2005. 282, Suhrkamp.

[serval:BIB_49779BDBD3AE]

Digital holographic microscopy: a noninvasive contrast imaging technique allowing quantitative visualization of living cells with subwavelength axial accuracy.

Marquet P., Rappaz B., Magistretti P.J., Cuche E., Emery Y., Colomb T., Depeursinge C., 2005. Optics letters, 30 (5) pp. 468-70. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B18D1C7F85BB]

Drug monitoring during substitution treatment

Eap Chin-Bin, 2005. pp. 15-16 dans European Psychiatry. Peer-reviewed.

[serval:BIB_D5920E27A014]

Dysregulation of glutamate cysteine ligase in schizophrenia

Gysin René, Tosic Mirjana, Chappuis Céline, Deppen Patricia, Ruiz Viviane, Bovet Pierre, Cuénod Michel, Do Kim Quang, 2005. dans , Abstracts - Society for Neuroscience. Peer-reviewed.

[serval:BIB_D58471281D47]

Editorial: International Meeting on pharmacovigilance in psychiatry, therapeutic drug monitoring and pharmacogenetics of psychotropic drugs

Baumann Pierre, Aldenhoff Josef, 2005. Pharmacopsychiatry, 38 (1) p. 41.

[WoS][serval:BIB_149606563DBE]

Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.

de Mendonça Lima C.A., Baumann P., Brawand-Amey M., Brogli C., Jacquet S., Cochard N., Powell-Golay K., Eap C.B., 2005. Progress in neuro-psychopharmacology & biological psychiatry, 29 (6) pp. 952-6. Peer-reviewed.

[DOI][Pmid][serval:BIB_B89A5097AC12]

Evidenz in der Pharmakovigilanz

Schuhmann Thomas, Eich Philipp, Baumann Pierre, 2005. PSY and PSY pp. 52-53.

[serval:BIB_59B19FEEE63F]

Fate of psychotropic drugs at the blood-brain-barrier and in the brain: pharmacokinetic, pharmacodynamic and clinical consequences

Baumann Pierre, Nikisch Georg, Tauscher J., 2005. p. 120 dans , European Psychiatry. Peer-reviewed.

[serval:BIB_0FA46DAFFB71]

Follow-up of a pharmacovigilance study in psychiatry involving TDM and pharmacogenetic testing

Jaquenoud Sirot Eveline, Eap Chin-Bin, Baumann Pierre, 2005. pp. 54-55 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_3EC852015E30]

Gene expression deficit in glutathione synthesis: role in the disconnectivity syndrome of schizophrenia

Do Kim Quang, Tosic Mirjana, Bovet Pierre, Cabungcal Jan Harry, Deppen Patricia, Gheorghita F., Hornung J.P., Preisig Martin, Sagara M., Schenk Françoise et al., 2005. p. 288 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_E0F818516EB6]

Genetic polymorphisms of psychotropic drug metabolizing enzymes: clinical relevance

Baumann Pierre, Jaquenoud Eveline, Eap Chin-Bin, 2005. p. 103 dans , European Psychiatry. Peer-reviewed.

[serval:BIB_8AFA09447E4C]

Glutathione deficit during development induces anomalies in anterior cingulate GABA interneurones: relevance to schizophrenia

Cabungcal Jan Harry, Nicolas D., Cuénod Michel, Do Kim Quang, Hornung J.P., 2005. p. 258 dans , Schizophrenia Bulletin. Peer-reviewed.

[DOI][serval:BIB_7432042F1EC7]

High sedation with low doses of atypical antipsychotics in 3 young patients (13 to 14 years old)

Holzer Laurent, Eap Chin-Bin, Halfon Olivier, Baumann Pierre, 2005. p. 53 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_3EA7258F91FD]

Hypoxia/hypoglycemia preconditioning prevents the loss of functional electrical activity in organotypic slice cultures.

Badaut J., Hirt L., Price M., de Castro Ribeiro M., Magistretti P.J., Regli L., 2005. Brain research, 1051 (1-2) pp. 117-22. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1121C9D0B715]

Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.

Bondolfi G., Morel F., Crettol S., Rachid F., Baumann P., Eap C.B., 2005. Therapeutic drug monitoring, 27 (4) pp. 539-43. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_08E3B822BB7E]

Influence of CYP2B6 polymorphism on the steady-state plasma levels of the enantiomers of methadone

Crettol Séverine, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Gottuey I., Haemming R., Monnat Martine, Haottemann H., Baumann Pierre, Eap Chin-Bin, 2005. p. 121 dans NA, Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.

[serval:BIB_87B68E9596B7]

International meeting on pharmacovigilance in psychiatry, therapeutic drug monitoring and pharmacogenetics of psychotropic drugs

Baumann Pierre, Aldenhoff Joseph, 2005. Pharmacopsychiatry, 38 (1) p. 41. Peer-reviewed.

[DOI][WoS][serval:BIB_252C5AD60AFD]

Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

Nikisch G., Mathé A.A., Czernik A., Thiele J., Bohner J., Eap C.B., Agren H., Baumann P., 2005. Psychopharmacology, 181 (4) pp. 751-60. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_01B5984DAAF6]

Measurement of the integral refractive index and dynamic cell morphometry of living cells with digital holographic microscopy.

Rappaz B., Marquet P., Cuche E., Emery Y., Depeursinge C., Magistretti P., 2005. Optics Express, 13 (23) pp. 9361-9373. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5BFB4C9AC860]

Metabolism of citalopram by MAO: pharmacogenetic and kinetic animal studies

Paus Erik, Lepore M., Jonzier Perey Michèle, Rochat B., Hornung J.P., Baumann Pierre, 2005. p. 59 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_C2656082C107]

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.

Crettol S., Déglon J.J., Besson J., Croquette-Krokkar M., Gothuey I., Hämmig R., Monnat M., Hüttemann H., Baumann P., Eap C.B., 2005. Clinical pharmacology and therapeutics, 78 (6) pp. 593-604. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DEE85807A54C]

Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.

Leuba G., Wernli G., Vernay A., Kraftsik R., Mohajeri M.H., Saini K.D., 2005. Dementia and geriatric cognitive disorders, 19 (4) pp. 171-83. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_46D17A388EDD]

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.

Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathé A.A., 2005. International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (cinp), 8 (3) pp. 403-410. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FE00FBD3FF24]

Neuropeptides in CNS of depressed patients and "depressed" animals: effect fo antidepressant treatments

Mathé Aleksander A., Baumann Pierre, Husum Henriette, Jiménez Patricia, Nikisch Georg, Agren Hans, 2005. p. 96 dans , World Journal of Biological Psychiatry. Peer-reviewed.

[serval:BIB_988387B336F1]

Optimisation of psychopharmacotherapy: clinical relevance of pharmacogenetic tests and therapeutic drug monitoring

Baumann Pierre, Jaquenoud Sirot Eveline, Eap Chin-Bin, 2005. p. 229 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_652EBA008707]

Pharmacokinetics and pharmacogenetics of methadone : clinical relevance

Eap Chin-Bin, Déglon Jean-Jacques, Baumann Pierre, 2005. dans Heroin-assisted treatment : work in progress / ed. by Margret Rihs-Middel...[et al.]. - Bern : H. Huber, 2005. - P. 251-265. - ISBN 3-456-83899-9.

[serval:BIB_259C666AFF75]

Plasma-CSF concentrations relationship of psychotropic drugs

Baumann Pierre, Nikisch Georg, Eap Chin-Bin, 2005. p. 43 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_91DED83B98B8]

Prescribing practices in German and Swiss psychiatric university and in non-university hospitals : national differences

Zullino Daniele Fabio, Mayland G., Schmidt L.G., Fähndrich E., Greil Waldemar, Horvath Andreas, Rüther Eckhardt, Engel R., Hippius H., Baumann Pierre, 2005. International Journal of Clinical Pharmacology and Therapeutics, 43 (7) pp. 339-349. Peer-reviewed.

[WoS][Pmid][serval:BIB_C5E6EF4E0DF1]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition